Expertise in
28
conditions

Dr. Najm M. Soofi

Gastroenterology
CDC Management Services LLC
5300 Elliott Dr, 
Ypsilanti, MI 
Accepting New Patients
Offers Telehealth
Expertise in
28
conditions
CDC Management Services LLC
5300 Elliott Dr, 
Ypsilanti, MI 

Overview

Najm Soofi is a Gastroenterologist practicing medicine in Ypsilanti, Michigan.

Dr. Soofi is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Familial Adenomatous Polyposis, Turcot Syndrome, Gardner Syndrome, Colonoscopy, and Endoscopy.

He is actively involved in clinical research, participating in 7 clinical trials. Dr. Soofi is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in MI

Hospital Affiliations

Trinity Health Ann Arbor Hospital
Trinity Health Livingston Hospital
Chelsea Hospital

Languages Spoken

English
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

CDC Management Services LLC
5300 Elliott Dr, Ypsilanti, MI 48197

Additional Areas of Focus

Dr. Soofi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2026
Intervention Type: Biological
Study Drug: Vedolizumab
Study Phase: Phase 4
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
29
conditions
Dr. Robert J. Fontana
Gastroenterology | Transplant Surgery
Expertise in
29
conditions
Dr. Robert J. Fontana
Gastroenterology | Transplant Surgery
Referral may be required

East Ann Arbor Ambulatory Surgery & Medical Procedures Center

4270 Plymouth Rd, Entrance 4, 
Ann Arbor, MI 
 (3.4 miles away)
734-936-9250
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Fontana is a Professor of Medicine and Director of the Transplant Hepatology Fellowship Program. He is recognized as a national and international expert in managing patients with cirrhosis, portal hypertension and nearly all forms of acute and chronic liver disease. He has particular research interest in patients with drug induced liver injury, viral hepatitis, and genetic liver disease. Dr. Fontana is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Hepatitis C, Liver Transplant, and Endoscopy. Dr. Fontana is board certified in Gastroenterology and Transplant Hepatology. Dr. Fontana is currently accepting new patients.

Expertise in
26
conditions
Dr. Anna S. Lok
Gastroenterology | Hepatology
Expertise in
26
conditions
Dr. Anna S. Lok
Gastroenterology | Hepatology
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
 (4.0 miles away)
844-233-0433
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Anna Lok is a Gastroenterologist and a Hepatologist practicing medicine in Ann Arbor, Michigan. Dr. Lok is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Hepatitis, Hepatitis C, Hepatitis B, Non-Alcoholic Fatty Liver Disease, and Liver Transplant. Dr. Lok is currently accepting new patients.

Expertise in
27
conditions
Dr. Neehar D. Parikh
Gastroenterology | Transplant Surgery
Expertise in
27
conditions
Dr. Neehar D. Parikh
Gastroenterology | Transplant Surgery
Referral may be required

Rogel Cancer Center

1500 E Medical Center Dr, Floor B1 Reception E, 
Ann Arbor, MI 
 (4.0 miles away)
734-647-8902
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

I am a transplant hepatologist and clinical researcher committed to the care of patients with liver cancer and advanced liver disease. I serve as the Medical Director of the Multidisciplinary Liver Tumor Clinic and Medical Director of the Living Donor Liver Transplantation Program. I believe that patients should have an active voice in their care and I work jointly with patients to ensure that their needs are met. Dr. Parikh is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Cirrhosis, Liver Failure, Liver Transplant, and Endoscopy. Dr. Parikh is board certified in Gastroenterology and Transplant Hepatology. Dr. Parikh is currently accepting new patients.

Frequently Asked Questions about Dr. Najm M. Soofi

How do I make an appointment with Dr. Najm M. Soofi?

You can book an appointment with Dr. Najm M. Soofi by calling their office at 734-434-6262. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Najm M. Soofi a top-rated expert for Familial Adenomatous Polyposis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Najm M. Soofi is classified as an Distinguished expert for Familial Adenomatous Polyposis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Najm M. Soofi specialize in?

While Dr. Najm M. Soofi is a Gastroenterology, they have specific expertise in Familial Adenomatous Polyposis, Turcot Syndrome, and Gardner Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Najm M. Soofi accept my insurance?

Dr. Najm M. Soofi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-434-6262 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Soofi's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 21 Advanced Conditions
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile